Biogen (BIIB) PT Lowered to $284 at Stifel, Following Earnings
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $216.04 -0.28%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on Biogen (NASDAQ: BIIB) to $284.00 (from $294.00) while maintaining a Hold rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
- Raymond James Starts Arrow Financial Corporation (AROW) at Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Stifel, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
